Aspirin
Aspirin 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Diabete Type 2、Cardiovascular Diseases。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
13 项
已进入 III/IV 期
9 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Montreal Heart Institute
- Mazandaran University of Medical Sciences
- Xijing Hospital
- University Hospital, Clermont-Ferrand
- Xuanwu Hospital, Beijing
- Zunyi Medical College
- Jung-min Ahn
- Siriraj Hospital
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
Iran、中国、法国、South Korea、Thailand、美国、德国、Poland、中国香港
正在招募患者的 Aspirin 研究
Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke
II 期 / III 期招募中IranNCT06653348Low-dose NOAC Versus GDMT After LAAO
不适用招募中中国NCT05960721Helping Osteoarthritis Patients to Walk With NSAID
IV 期招募中法国NCT05761015Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
不适用招募中中国NCT05899582Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
IV 期招募中中国NCT06013020ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
IV 期招募中South KoreaNCT06676280Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance
III 期招募中ThailandNCT06740916Postpartum Low-Dose Aspirin and Preeclampsia
II 期招募中美国NCT03667326Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
III 期招募中法国NCT04356326Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
不适用招募中中国NCT07441382Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation
不适用招募中中国NCT07677410Treatment With Aspirin After Preeclampsia: TAP Trial
IV 期招募中美国NCT06281665Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma
不适用招募中中国NCT07240454OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
不适用招募中South KoreaNCT07198529Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
IV 期招募中South KoreaNCT04014803Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
不适用招募中德国PolandNCT04298723Stand By Me: Anti-Drug Elite Adventure-Based Training Program
不适用招募中中国香港NCT07064343Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
不适用招募中美国NCT06943586Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
III 期招募中美国NCT03907046Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
III 期招募中中国NCT07776873Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
IV 期招募中中国NCT07349875Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis
不适用招募中中国NCT05885932The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia
III 期招募中South KoreaNCT05287321Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
IV 期招募中PolandNCT04695106
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。